Literature DB >> 26451351

Evaluation of Effective MMP Inhibitors from Eight Different Brown Algae in Human Fibrosarcoma HT1080 Cells.

Min Joo Bae1, Fatih Karadeniz2, Byul-Nim Ahn3, Chang-Suk Kong1.   

Abstract

Matrix metalloproteinases (MMPs) are crucial extracellular matrices degrading enzymes that have important roles in metastasis of cancer progression as well as other significant conditions such as oxidative stress and hepatic fibrosis. Marine plants are on the rise for their potential to provide natural products that exhibit remarkable health benefits. In this context, brown algae species have been of much interest in the pharmaceutical field with reported instances of isolation of bioactive compounds against tumor growth and MMP activity. In this study, eight different brown algae species were harvested, and their extracts were compared in regard to their anti-MMP effects. According to gelatin zymography results, Ecklonia cava, Ecklonia bicyclis, and Ishige okamurae showed higher inhibitory effects than the other samples on MMP-2 and -9 activity at the concentrations of 10, 50, and 100 μg/mL. However, only I. okamurae was able to regulate the MMP activity through the expression of MMP and tissue inhibitor of MMP observed by mRNA levels. Overall, brown algae species showed to be good sources for anti-MMP agents, while I. okamurae needs to be further studied for its potential to yield pharmaceutical molecules that can regulate MMP-activity through cellular pathways as well as enzymatic inhibition.

Entities:  

Keywords:  MMP-2; TIMP-2; brown algae; matrix metalloproteinase (MMP)-9; tissue inhibitor of MMP (TIMP)-1

Year:  2015        PMID: 26451351      PMCID: PMC4596340          DOI: 10.3746/pnf.2015.20.3.153

Source DB:  PubMed          Journal:  Prev Nutr Food Sci        ISSN: 2287-1098


  20 in total

Review 1.  Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion.

Authors:  Dimitra Bourboulia; William G Stetler-Stevenson
Journal:  Semin Cancer Biol       Date:  2010-05-12       Impact factor: 15.707

Review 2.  The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity.

Authors:  Keith Brew; Hideaki Nagase
Journal:  Biochim Biophys Acta       Date:  2010-01-15

3.  Control of matrix metalloproteinase activity in cancer.

Authors:  J L Jones; R A Walker
Journal:  J Pathol       Date:  1997-12       Impact factor: 7.996

Review 4.  New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor progression.

Authors:  Brigitte Bauvois
Journal:  Biochim Biophys Acta       Date:  2011-10-12

Review 5.  Strategies for MMP inhibition in cancer: innovations for the post-trial era.

Authors:  Christopher Mark Overall; Carlos López-Otín
Journal:  Nat Rev Cancer       Date:  2002-09       Impact factor: 60.716

Review 6.  Matrix metalloproteinases: changing roles in tumor progression and metastasis.

Authors:  Laurie A Shuman Moss; Sandra Jensen-Taubman; William G Stetler-Stevenson
Journal:  Am J Pathol       Date:  2012-10-12       Impact factor: 4.307

Review 7.  Matrix metalloproteinase inhibitors (MMPIs) from marine natural products: the current situation and future prospects.

Authors:  Chen Zhang; Se-Kwon Kim
Journal:  Mar Drugs       Date:  2009-03-31       Impact factor: 5.118

Review 8.  Hepatic fibrosis.

Authors:  Jingjing Jiao; Scott L Friedman; Costica Aloman
Journal:  Curr Opin Gastroenterol       Date:  2009-05       Impact factor: 3.287

9.  Screening for bioactive compounds from algae.

Authors:  M Plaza; S Santoyo; L Jaime; G García-Blairsy Reina; M Herrero; F J Señoráns; E Ibáñez
Journal:  J Pharm Biomed Anal       Date:  2009-03-25       Impact factor: 3.935

Review 10.  Chemical structures and bioactivities of sulfated polysaccharides from marine algae.

Authors:  Guangling Jiao; Guangli Yu; Junzeng Zhang; H Stephen Ewart
Journal:  Mar Drugs       Date:  2011-02-08       Impact factor: 6.085

View more
  3 in total

1.  Inhibitory Effect of Hizikia fusiformis Solvent-Partitioned Fractions on Invasion and MMP Activity of HT1080 Human Fibrosarcoma Cells.

Authors:  Seul-Gi Lee; Fatih Karadeniz; Jung Hwan Oh; Ga Hyun Yu; Chang-Suk Kong
Journal:  Prev Nutr Food Sci       Date:  2017-09-30

2.  Enzyme-treated Ecklonia cava extract inhibits adipogenesis through the downregulation of C/EBPα in 3T3-L1 adipocytes.

Authors:  In-Hye Kim; Taek-Jeong Nam
Journal:  Int J Mol Med       Date:  2017-01-26       Impact factor: 4.101

Review 3.  Recent advances in pharmacological research on Ecklonia species: a review.

Authors:  Prashamsa Koirala; Hyun Ah Jung; Jae Sue Choi
Journal:  Arch Pharm Res       Date:  2017-08-24       Impact factor: 4.946

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.